The independent source for health policy research, polling, and news.
221 - 232 of 232 Results
After Angelina Jolie disclosed her genetic predisposition for breast cancer, demand for genetic tests went up. Counselors help interpret those tests, and demand for their services has increased, too.
Researchers found that the facility fees hospitals and their clinics routinely add to the bill helps drive the price increases.
An MIT economist and Harvard oncologist propose offering loans to patients to cover the cost of expensive, curative drugs, financed by private sector investment in loan securities.
Terminal patients and doctors prepare themselves for California’s new assisted suicide law, which takes effect June 9.
The decision by Independence Blue Cross of Pennsylvania to pay for whole genome sequencing for some cancer patients adds to the debate about how to handle these expensive tests.
Families USA and the Institute for Clinical and Economic Review are collaborating on a series of patient guides on treatment and screenings.
CT scans, which are administered more than 85 million times a year, are an important diagnostic tool, but just one can be equivalent to 200 X-rays. Some doctors warn that health providers are not considering possible consequences when ordering the tests.
The plans can help workers cover their high deductibles, but the policies also have limitations.
The health law waived Medicare’s Part B deductible and dropped the 20 percent copayment for the preventive tests.
Some medicines, particularly intravenous treatments, are not listed in plans’ pharmacy benefit section and, therefore, it’s difficult to confirm coverage specifics.
The advocacy arm of the American Cancer Society said Wednesday that federal and state governments should move to restrict insurers from charging patients a percentage of the cost of their prescription drugs.
Researchers found Medi-Cal patients were diagnosed later, were less likely to receive recommended treatment and had lower survival rates.
© 2026 KFF